RU2015156417A - Лосмапимод для применения в лечении гломерулярного заболевания - Google Patents
Лосмапимод для применения в лечении гломерулярного заболевания Download PDFInfo
- Publication number
- RU2015156417A RU2015156417A RU2015156417A RU2015156417A RU2015156417A RU 2015156417 A RU2015156417 A RU 2015156417A RU 2015156417 A RU2015156417 A RU 2015156417A RU 2015156417 A RU2015156417 A RU 2015156417A RU 2015156417 A RU2015156417 A RU 2015156417A
- Authority
- RU
- Russia
- Prior art keywords
- glomerular disease
- compound
- cyclopropylcarbamoyl
- dimethylpropyl
- nicotinamide
- Prior art date
Links
- 208000022461 Glomerular disease Diseases 0.000 title claims 12
- 231100000852 glomerular disease Toxicity 0.000 title claims 12
- KKYABQBFGDZVNQ-UHFFFAOYSA-N 6-[5-[(cyclopropylamino)-oxomethyl]-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)-3-pyridinecarboxamide Chemical compound CC1=C(F)C=C(C(=O)NC2CC2)C=C1C1=CC=C(C(=O)NCC(C)(C)C)C=N1 KKYABQBFGDZVNQ-UHFFFAOYSA-N 0.000 title claims 6
- 229950003265 losmapimod Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims 8
- 150000003839 salts Chemical class 0.000 claims 5
- 241000725303 Human immunodeficiency virus Species 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 201000005206 focal segmental glomerulosclerosis Diseases 0.000 claims 2
- 231100000854 focal segmental glomerulosclerosis Toxicity 0.000 claims 2
- 208000017169 kidney disease Diseases 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 2
- 208000024985 Alport syndrome Diseases 0.000 claims 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 claims 1
- 206010018372 Glomerulonephritis membranous Diseases 0.000 claims 1
- 208000024869 Goodpasture syndrome Diseases 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- 206010037601 Pyelonephritis chronic Diseases 0.000 claims 1
- 206010002022 amyloidosis Diseases 0.000 claims 1
- 201000006368 chronic pyelonephritis Diseases 0.000 claims 1
- 208000033679 diabetic kidney disease Diseases 0.000 claims 1
- 239000012458 free base Substances 0.000 claims 1
- 230000001434 glomerular Effects 0.000 claims 1
- 208000003215 hereditary nephritis Diseases 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 201000008350 membranous glomerulonephritis Diseases 0.000 claims 1
- 231100000855 membranous nephropathy Toxicity 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 201000008383 nephritis Diseases 0.000 claims 1
- 201000006292 polyarteritis nodosa Diseases 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 239000003053 toxin Substances 0.000 claims 1
- 231100000765 toxin Toxicity 0.000 claims 1
- 108700012359 toxins Proteins 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361844491P | 2013-07-10 | 2013-07-10 | |
| US61/844,491 | 2013-07-10 | ||
| PCT/EP2014/064508 WO2015004089A1 (en) | 2013-07-10 | 2014-07-08 | Losmapimod for use in treating glomerular disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2015156417A true RU2015156417A (ru) | 2017-08-15 |
Family
ID=51134104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2015156417A RU2015156417A (ru) | 2013-07-10 | 2014-07-08 | Лосмапимод для применения в лечении гломерулярного заболевания |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9707219B2 (enExample) |
| EP (1) | EP3019168A1 (enExample) |
| JP (1) | JP2016523943A (enExample) |
| KR (1) | KR20160030206A (enExample) |
| CN (1) | CN105358148A (enExample) |
| AU (1) | AU2014289296A1 (enExample) |
| CA (1) | CA2917277A1 (enExample) |
| RU (1) | RU2015156417A (enExample) |
| WO (1) | WO2015004089A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10342786B2 (en) * | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
| JP2021501130A (ja) | 2017-10-05 | 2021-01-14 | フルクラム セラピューティクス，インコーポレイテッド | ＤＵＸ４の発現を低減するためのｐ３８阻害剤の使用 |
| US20200085810A1 (en) * | 2018-07-26 | 2020-03-19 | Hoffmann-La Roche Inc. | Compounds for use in treating kidney disorders |
| GB201821138D0 (en) * | 2018-12-21 | 2019-02-06 | Benevolentai Bio Ltd | Compositions and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4472349B2 (ja) * | 2002-02-12 | 2010-06-02 | スミスクライン ビーチャム コーポレーション | ｐ３８阻害薬として有用なニコチンアミド誘導体 |
| KR20070074576A (ko) * | 2004-10-29 | 2007-07-12 | 코와 가부시키가이샤 | 사구체 질환 치료제 |
| GB0612026D0 (en) * | 2006-06-16 | 2006-07-26 | Smithkline Beecham Corp | New use |
| IN2014KN02981A (enExample) * | 2012-07-17 | 2015-05-08 | Glaxosmithkline Llc |
-
2014
- 2014-07-08 CN CN201480038296.4A patent/CN105358148A/zh active Pending
- 2014-07-08 EP EP14735983.0A patent/EP3019168A1/en not_active Withdrawn
- 2014-07-08 CA CA2917277A patent/CA2917277A1/en not_active Abandoned
- 2014-07-08 US US14/903,694 patent/US9707219B2/en not_active Expired - Fee Related
- 2014-07-08 AU AU2014289296A patent/AU2014289296A1/en not_active Abandoned
- 2014-07-08 JP JP2016524786A patent/JP2016523943A/ja active Pending
- 2014-07-08 WO PCT/EP2014/064508 patent/WO2015004089A1/en not_active Ceased
- 2014-07-08 RU RU2015156417A patent/RU2015156417A/ru not_active Application Discontinuation
- 2014-07-08 KR KR1020167002417A patent/KR20160030206A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015004089A1 (en) | 2015-01-15 |
| US9707219B2 (en) | 2017-07-18 |
| KR20160030206A (ko) | 2016-03-16 |
| CN105358148A (zh) | 2016-02-24 |
| US20160220550A1 (en) | 2016-08-04 |
| AU2014289296A1 (en) | 2016-02-04 |
| EP3019168A1 (en) | 2016-05-18 |
| JP2016523943A (ja) | 2016-08-12 |
| CA2917277A1 (en) | 2015-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014511892A5 (enExample) | ||
| JP2014511891A5 (enExample) | ||
| MY192354A (en) | 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as btk-inhibitors | |
| JP2014507455A5 (enExample) | ||
| MX383706B (es) | Composiciones de cenicriviroc y métodos para elaborarlas y usarlas. | |
| EA201791019A1 (ru) | Полициклические карбамоилпиридоновые соединения и их фармацевтическое применение | |
| JP2018507877A5 (enExample) | ||
| JP2016530259A5 (enExample) | ||
| RU2017105353A (ru) | Соединения | |
| JP2017527561A5 (enExample) | ||
| EA201791872A1 (ru) | Полициклические карбамоилпиридоновые соединения и их фармацевтическое применение | |
| EA200800881A1 (ru) | Лекарственная форма пирфенидона в виде капсул с фармацевтически приемлемыми эксципиентами | |
| EA201892415A1 (ru) | Полиморфная форма n-{6-(2-гидроксипропан-2-ил)-2-[2-(метилсульфонил)этил]-2н-индазол-5-ил}-6-(трифторметил)пиридин-2-карбоксамида | |
| PH12020500543A1 (en) | Nonracemic mixtures and uses thereof | |
| ME02841B (me) | Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze | |
| HRP20220683T1 (hr) | Liječenje parkinsonove bolesti | |
| PE20170773A1 (es) | Formulaciones farmaceuticas, procesos para la preparacion, y metodos de uso | |
| RU2015156417A (ru) | Лосмапимод для применения в лечении гломерулярного заболевания | |
| JP2016537338A5 (enExample) | ||
| EA201500513A1 (ru) | Продукт сомикронизации, включающий ацетат улипристала | |
| RU2015135824A (ru) | Бициклические соединения пиримидона в качестве ингибиторов lp-pla2 | |
| RU2016112257A (ru) | Композиция для лечения гипертензии и/или фиброза | |
| RU2016151973A (ru) | Пиридиноны, замещенные фенилом и трет-бутилуксусной кислотой, обладающие анти-вич эффектами | |
| EA201792237A1 (ru) | Фармацевтические составы | |
| JP2016523943A5 (enExample) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA93 | Acknowledgement of application withdrawn (no request for examination) |
Effective date: 20170710 |